NCT06520995 Elderly Patients With Type 2 Diabetes and Cognitive Exercises
| NCT ID | NCT06520995 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Istanbul University - Cerrahpasa |
| Condition | Cognitive Impairment |
| Study Type | INTERVENTIONAL |
| Enrollment | 90 participants |
| Start Date | 2024-04-01 |
| Primary Completion | 2025-02-28 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 90 participants in total. It began in 2024-04-01 with a primary completion date of 2025-02-28.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study was planned as a single-center, prospective randomized controlled study. Individuals over 65 years of age with type 2 diabetes without severe cognitive impairment will be included in the study. The primary aim of the study is to improve the cognitive functions of the patients after the interventions. The secondary aim is to strengthen patients' diabetes self-management and increase their quality of life, especially by improving their glycemic control. For these purposes, in our study, patients will be randomized into three groups: "cognitive exercise and diabetes education", "diabetes education only" and "control" group. The control group will be provided with standard outpatient diabetes education. Individuals who will be in the "cognitive exercise and video training" group will watch a total of 12 diabetes education videos prepared by the researcher, in which a different topic will be discussed every week for 3 months, and they will also participate cognitive exercises for 15-20 minutes a day for 3 months via a mobile application. Individuals in the "diabetes education only" group will similarly watch a total of 12 diabetes education videos prepared by the researchers. Patients will be evaluated in terms of cognitive function, psychosocial problems (anxiety, depression, stress), glycemic control (HbA1c), diabetes management and quality of life before the interventions, at 3 months and 6 months.
Eligibility Criteria
Inclusion Criteria: * Diagnosed with type 2 diabetes for at least one year * Literate * Able to use smartphone/tablet/computer and have internet access * Individuals who agree to participate in the study will be included. Exclusion Criteria: * Type 1 diabetes * With severe cognitive impairment * Known neurological or psychiatric disorders * Severely depressed * Individuals with disabilities (vision, hearing problems, etc.) will not be included in the study
Contact & Investigator
Zeliha Tulek, RN,Prof. Dr.
STUDY DIRECTOR
Istanbul University-Cerrahpasa, Florence Nightingale Faculty of Nursing
Frequently Asked Questions
Who can join the NCT06520995 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, studying Cognitive Impairment. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06520995 currently recruiting?
Yes, NCT06520995 is actively recruiting participants. Contact the research team at habulut@ku.edu.tr for enrollment information.
Where is the NCT06520995 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT06520995 clinical trial?
NCT06520995 is sponsored by Istanbul University - Cerrahpasa. The principal investigator is Zeliha Tulek, RN,Prof. Dr. at Istanbul University-Cerrahpasa, Florence Nightingale Faculty of Nursing. The trial plans to enroll 90 participants.